Table 1 Distribution of receptor status by tumour size, grade and LN involvement
Tumour size | Receptor status | ||||||||
|---|---|---|---|---|---|---|---|---|---|
ER+ | ER- | Total | PR+ | PR- | Total | Her2+ | Her2- | Total | |
T1 | 9 (17.6) | 8 (7.7) | 17 (11.0) | 7 (17.5) | 9 (7.9) | 16 (10.4) | 4 (10.8) | 12 (10.8) | 16 (10.0) |
T2 | 24 (47.1) | 47 (45.2) | 71 (45.8) | 21 (52.3) | 50 (43.9) | 71 (46.1) | 17 (46.9) | 49 (44.1) | 66 (44.6) |
T3 | 12 (20.6) | 30 (28.8) | 42 (27.1) | 6 (15.0) | 36 (31.6) | 42 (27.3) | 9 (24.3) | 33 (29.7) | 42 (28.4) |
T4 | 6 (11.8) | 19 (18.3) | 25 (6.1) | 6 (15.0) | 19 (16.7) | 25 (16.2) | 7 (18.9) | 17 (15.3) | 24 (16.2) |
Total | 51 | 104 | 155 | 40 | 114 | 154 | 37 | 111 | 148 |
Tumour grade | |||||||||
1 | 5 (50) | 5 (50) | 10 | 4 (40) | 6 (60) | 10 | 3 (33.3) | 6 (66.7) | 9 |
2 | 24 (32.9) | 49 (67.1) | 73 | 23 (31.9) | 49 (68.1) | 72 | 21 (30.4) | 48 (69.6) | 69 |
3 | 8 (21.6) | 29 (78.4) | 37 | 5 (13.5) | 32 (86.5) | 37 | 8 (22.2) | 28 (77.8) | 36 |
Total | 37 | 83 | 120 | 32 | 87 | 119 | 32 | 82 | 114 |
Lymph node positivity | |||||||||
N0 | 12 (25.5) | 35 (74.5) | 47 | 8 (17.0) | 39 (83.0) | 47 | 11 (25.0) | 33 (75.0) | 44 |
N1 | 13 (32.1) | 22 (62.9) | 35 | 12 (34.3) | 23 (65.7) | 35 | 8 (25.0) | 24 (75.0) | 32 |
N2 | 16 (34.8) | 30 (65.2) | 46 | 10 (22.2) | 35 (77.8) | 45 | 12 (26.1) | 34 (73.9) | 46 |
N3 | 2 (22.2) | 7 (77.8) | 9 | 0 (0) | 9 (100) | 9 | 3 (33.3) | 6 (66.7) | 9 |
Total | 43 | 94 | 137 | 30 | 106 | 136 | 34 | 97 | 131 |